Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

A Unique Case of Cervical Myelopathy in an Adult Patient with Scheie Syndrome.

Vazifehdan F, Karantzoulis VG, Ebner R, Igoumenou VG.

J Orthop Case Rep. 2017 Nov-Dec;7(6):27-30. doi: 10.13107/jocr.2250-0685.936.

2.

History of Neuro-Ophthalmology in Argentina.

Ribero Ayerza DM, de Virgiliis M, Ebner R.

J Neuroophthalmol. 2017 Sep;37(3):e11-e12. doi: 10.1097/WNO.0000000000000542. No abstract available.

PMID:
28622160
3.

A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.

Petrovics G, Li H, Stümpel T, Tan SH, Young D, Katta S, Li Q, Ying K, Klocke B, Ravindranath L, Kohaar I, Chen Y, Ribli D, Grote K, Zou H, Cheng J, Dalgard CL, Zhang S, Csabai I, Kagan J, Takeda D, Loda M, Srivastava S, Scherf M, Seifert M, Gaiser T, McLeod DG, Szallasi Z, Ebner R, Werner T, Sesterhenn IA, Freedman M, Dobi A, Srivastava S.

EBioMedicine. 2015 Oct 31;2(12):1957-64. doi: 10.1016/j.ebiom.2015.10.028. eCollection 2015 Dec.

4.

Complete Genome Sequence of Listeria monocytogenes N2306, a Strain Associated with the 2013-2014 Listeriosis Outbreak in Switzerland.

Tasara T, Ebner R, Klumpp J, Stephan R.

Genome Announc. 2015 May 28;3(3). pii: e00553-15. doi: 10.1128/genomeA.00553-15.

5.

Sixth nerve palsy + ipsilateral Horner's Syndrome = Parkinson's Syndrome.

Ebner RN, Ayerza DR, Aghetoni F.

Saudi J Ophthalmol. 2015 Jan-Mar;29(1):63-6. doi: 10.1016/j.sjopt.2014.09.010. Epub 2014 Oct 5.

6.

Sterile Seroma Resulting from Multilevel XLIF Procedure as Possible Adverse Effect of Prophylactic Vancomycin Powder: A Case Report.

Youssef JA, Orndorff DG, Scott MA, Ebner RE, Knewitz AP.

Evid Based Spine Care J. 2014 Oct;5(2):127-33. doi: 10.1055/s-0034-1386754.

7.

STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy.

Spitzner M, Ebner R, Wolff HA, Ghadimi BM, Wienands J, Grade M.

Cancers (Basel). 2014 Sep 29;6(4):1986-2011. doi: 10.3390/cancers6041986. Review.

8.

Incomplete description.

Ebner R.

Dtsch Arztebl Int. 2014 Jul 7;111(27-28):488. doi: 10.3238/arztebl.2014.0488a. No abstract available.

9.

[Guidelines for diagnosis, monitoring and treatment of Fabry disease].

Consenso de Médicos de AADELFA y GADYTEF, Neumann P, Antongiovanni N, Fainboim A, Kisinovsky I, Amartino H, Cabrera G, Carmona S, Ceci R, Cicerán A, Choua M, Doxastakis G, De Maio S, Ebner R, Escobar AM, Ferrari G, Forrester M, Guelbert N, Luna P, Marchesoni C, Masllorens F, Politei J, Reisin R, Ripeau D, Rozenfeld P, Serebrinsky G, Tarabuso AL, Trípoli J.

Medicina (B Aires). 2013;73(5):482-94. Spanish.

10.

STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo.

Spitzner M, Roesler B, Bielfeld C, Emons G, Gaedcke J, Wolff HA, Rave-Fränk M, Kramer F, Beissbarth T, Kitz J, Wienands J, Ghadimi BM, Ebner R, Ried T, Grade M.

Int J Cancer. 2014 Feb 15;134(4):997-1007. doi: 10.1002/ijc.28429. Epub 2013 Sep 3.

11.

Microarray-based characterization of Staphylococcus aureus isolates obtained from chicken carcasses.

Ebner R, Johler S, Sihto HM, Stephan R, Zweifel C.

J Food Prot. 2013 Aug;76(8):1471-4. doi: 10.4315/0362-028X.JFP-13-009.

PMID:
23905809
12.

Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy.

Kendziorra E, Ahlborn K, Spitzner M, Rave-Fränk M, Emons G, Gaedcke J, Kramer F, Wolff HA, Becker H, Beissbarth T, Ebner R, Ghadimi BM, Pukrop T, Ried T, Grade M.

Carcinogenesis. 2011 Dec;32(12):1824-31. doi: 10.1093/carcin/bgr222. Epub 2011 Oct 8.

13.

A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets.

Grade M, Hummon AB, Camps J, Emons G, Spitzner M, Gaedcke J, Hoermann P, Ebner R, Becker H, Difilippantonio MJ, Ghadimi BM, Beissbarth T, Caplen NJ, Ried T.

Int J Cancer. 2011 Mar 1;128(5):1069-79. doi: 10.1002/ijc.25453.

14.

Disease pathogenesis--clinical interpretation.

Hopwood J, Ebner R.

Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S41. No abstract available.

PMID:
20040310
15.

Spheroid-based drug screen: considerations and practical approach.

Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA.

Nat Protoc. 2009;4(3):309-24. doi: 10.1038/nprot.2008.226. Epub 2009 Feb 12.

PMID:
19214182
16.

Editorial.

Ebner R, Ried T.

Drug Discov Today Dis Mech. 2007;4(4):259-260. No abstract available.

17.

Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?

Friedrich J, Ebner R, Kunz-Schughart LA.

Int J Radiat Biol. 2007 Nov-Dec;83(11-12):849-71. Review.

PMID:
18058370
18.

A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assay.

Friedrich J, Eder W, Castaneda J, Doss M, Huber E, Ebner R, Kunz-Schughart LA.

J Biomol Screen. 2007 Oct;12(7):925-37. Erratum in: J Biomol Screen. 2007 Dec;12(8):1115-9.

PMID:
17942785
19.

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy.

Schmitz M, Temme A, Senner V, Ebner R, Schwind S, Stevanovic S, Wehner R, Schackert G, Schackert HK, Fussel M, Bachmann M, Rieber EP, Weigle B.

Br J Cancer. 2007 Apr 23;96(8):1293-301. Epub 2007 Mar 20. Erratum in: Br J Cancer. 2007 Jun 18;96(12):1928.

20.

Immunofluorescence detection of globotriaosylceramide deposits in conjunctival biopsies of Fabry disease patients.

Rozenfeld PA, Croxatto O, Ebner R, Fossati CA.

Clin Exp Ophthalmol. 2006 Sep-Oct;34(7):689-94.

PMID:
16970764
21.

A successful approach for the detection of Fabry patients in Argentina.

Rozenfeld PA, Tarabuso A, Ebner R, Ramallo G, Fossati CA.

Clin Genet. 2006 Apr;69(4):344-8.

PMID:
16630168
22.
23.

Expression biomarkers for clinical efficacy and outcome prediction in cancer.

Strand KJ, Khalak H, Strovel JW, Ebner R, Augustus M.

Pharmacogenomics. 2006 Jan;7(1):105-15. Review.

PMID:
16354128
24.

D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family.

Kiessling A, Weigle B, Fuessel S, Ebner R, Meye A, Rieger MA, Schmitz M, Temme A, Bachmann M, Wirth MP, Rieber EP.

Prostate. 2005 Sep 1;64(4):387-400.

PMID:
15761874
25.

Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas.

Weigle B, Ebner R, Temme A, Schwind S, Schmitz M, Kiessling A, Rieger MA, Schackert G, Schackert HK, Rieber EP.

Oncol Rep. 2005 Jan;13(1):139-44.

PMID:
15583815
26.

[Buprenorphine or methadone for detoxification of young opioid addicts?].

Ebner R, Schreiber W, Zierer C.

Psychiatr Prax. 2004 Nov;31 Suppl 1:S108-10. German.

PMID:
15570521
27.

Dysthyroid optic neuropathy (DON).

Ebner R.

Semin Ophthalmol. 2002 Mar;17(1):18-21. Review.

PMID:
15513451
28.

Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.

Ebner R, Devoto MH, Weil D, Bordaberry M, Mir C, Martinez H, Bonelli L, Niepomniszcze H.

Br J Ophthalmol. 2004 Nov;88(11):1380-6.

29.

Central retinal artery occlusion and ophthalmoplegia following spinal surgery.

Halfon MJ, Bonardo P, Valiensi S, Zaffaroni MC, Fernandez Pardal MM, Ribero Ayerza D, Ebner R, Anderson P, Reisin RC.

Br J Ophthalmol. 2004 Oct;88(10):1350-2. Review. No abstract available.

30.

D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate.

Weigle B, Fuessel S, Ebner R, Temme A, Schmitz M, Schwind S, Kiessling A, Rieger MA, Meye A, Bachmann M, Wirth MP, Rieber EP.

Biochem Biophys Res Commun. 2004 Sep 10;322(1):239-49.

PMID:
15313197
31.

The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.

Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R.

J Biomol Screen. 2004 Jun;9(4):273-85. Review.

PMID:
15191644
32.

Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.

Rieger MA, Ebner R, Bell DR, Kiessling A, Rohayem J, Schmitz M, Temme A, Rieber EP, Weigle B.

Cancer Res. 2004 Apr 1;64(7):2357-64.

33.

D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer.

Weigle B, Kiessling A, Ebner R, Fuessel S, Temme A, Meye A, Schmitz M, Rieger MA, Ockert D, Wirth MP, Rieber EP.

Int J Cancer. 2004 May 10;109(6):882-92.

34.

Computed tomographic scan of a dinosaur's skull: the optic canal.

Ebner R, Salgado L.

Arch Ophthalmol. 2003 Feb;121(2):294-5. No abstract available.

PMID:
12583808
35.

Papillary drusen and ocular hypertension.

Moussalli MA, Sanseau A, Ebner R.

Int Ophthalmol. 2001;23(4-6):275-8.

PMID:
11944851
36.

Measurement of the depth distribution of average LET and absorbed dose inside a water-filled phantom on board space station MIR.

Berger T, Hajek M, Schoner W, Fugger M, Vana N, Noll M, Ebner R, Akatov Y, Shurshakov V, Arkhangelsky V.

Phys Med. 2001;17 Suppl 1:128-30.

PMID:
11770528
37.

True, true and related?

Ebner R, DaCol E, Bullorsky E.

Surv Ophthalmol. 2001 May-Jun;45(6):489-92.

PMID:
11425355
38.

Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging.

Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, Ramella M, Manor RS, Fletcher WA, Repka MX, Garrity JA, Ebner RN, Monteiro ML, McFadzean RM, Rubtsova IV, Hoyt WF.

Arch Ophthalmol. 2001 Apr;119(4):516-29.

PMID:
11296017
39.

Optic neuropathy associated with laser in situ keratomileusis.

Lee AG, Kohnen T, Ebner R, Bennett JL, Miller NR, Carlow TJ, Koch DD.

J Cataract Refract Surg. 2000 Nov;26(11):1581-4.

PMID:
11084263
40.

Bilateral and simultaneous ischemic optic neuropathy following hip replacement surgery.

Bonardo P, Ebner R, Martínez O, Fernández Sasso E, Martínez H, Fernández Pardal M, Reisin R.

Neurologia. 2000 Jun-Jul;15(6):258-60.

PMID:
11002704
41.

Involvement of the visual pathway in hereditary neuropathy with liability to pressure palsies.

Schneider C, Reiners K, Friedl W, Ebner R, Toyka KV.

J Neurol. 2000 Mar;247(3):222-3. No abstract available.

PMID:
10787121
42.

A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity.

Shi Y, Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, Barber MC, Wang W, Wathen K, Hodge V, Fisher CL, Olsen H, Ruben SM, Knyazev I, Cho YH, Kao V, Wilkinson KA, Carrell JA, Ebner R.

J Biol Chem. 2000 Jun 23;275(25):19167-76.

43.
44.

A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.

Giovarelli M, Musiani P, Garotta G, Ebner R, Di Carlo E, Kim Y, Cappello P, Rigamonti L, Bernabei P, Novelli F, Modesti A, Coletti A, Ferrie AK, Lollini PL, Ruben S, Salcedo T, Forni G.

J Immunol. 1999 Nov 1;163(9):4886-93.

45.

A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.

Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS.

J Biol Chem. 1999 May 14;274(20):13733-6.

46.

Bone loss (osteopenia) in old male mice results from diminished activity and availability of TGF-beta.

Gazit D, Zilberman Y, Ebner R, Kahn A.

J Cell Biochem. 1998 Sep 15;70(4):478-88.

PMID:
9712146
47.

LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator.

Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG, Ware CF.

Immunity. 1998 Jan;8(1):21-30.

48.

The receptor for the cytotoxic ligand TRAIL.

Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM.

Science. 1997 Apr 4;276(5309):111-3.

49.

Limited chondro-osteogenesis by recombinant human transforming growth factor-beta 1 in calvarial defects of adult baboons (Papio ursinus).

Ripamonti U, Bosch C, van den Heever B, Duneas N, Melsen B, Ebner R.

J Bone Miner Res. 1996 Jul;11(7):938-45.

PMID:
8797114

Supplemental Content

Support Center